C ardiovascular dysfunction is a major consequence of septic shock and contributes to the high morbidity and mortality of sepsis (1). Increasing evidence suggests that innate immune and inflammatory responses are involved in the pathophysiology of sepsis, shock, and multipleorgan failure, which ultimately leads to death (2). However, the mechanisms by which innate immune and inflammatory responses are involved in myocardial dysfunction during septic shock have remained unclear.
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For and inflammatory responses (3) . TLRs recognize pathogen-associated molecular patterns and transduce a signal into the cells (3) . For example, TLRs (TLR1, TLR2, TLR4, TLR5, and TLR6) that are expressed on the cell surface are involved in the recognition of structures unique to bacteria or fungi, while TLRs that are localized in intracellular compartments (TLR3, TLR7, TLR8, and TLR9) recognize viral or bacterial nucleic acids (4) . TLRs have been implicated in cardiac dysfunction in several important disease states, including ischemia/reperfusion injury (5) , congestive heart failure (6) , and septic shock (7, 8) . TLR-mediated signaling predominately activates nuclear factor-κB (NF-κB) which is an important transcription factor controlling the expression of inflammatory cytokine genes. In addition to us, other investigators have also reported that TLR4-mediated NF-κB activation plays an important role in mediating the pathophysiology of cecal ligation and puncture (CLP)-induced sepsis/septic shock (8) (9) (10) . TLR3 is located in intracellular endosomes, and recognizes double-stranded RNA and polyinosinic-polycytidylic acid (Poly I:C, a synthetic analogue of doublestranded RNA), resulting in the induction of antiviral immune responses (11) . TLR3 also recognized by-products from apoptotic and necrotic cells (12) (13) (14) . More significantly, a recent study by Cavassani et al (12) demonstrated that TLR3 deficient (TLR3 −/− ) mice showed an increased survival rate in CLP-septic mice. Administration of anti-TLR3 antibody to wildtype (WT) mice increased the survival rate in CLP-septic mice (12) . This study suggests that TLR3 contributes to the pathophysiology of sepsis/septic shock. However, the role of TLR3 in cardiac dysfunction during the development of sepsis/septic shock has not been investigated.
In the present study, we examined the role of TLR3 in cardiac function during CLP-induced sepsis. We observed that TLR3 −/− mice exhibited protection against CLP-induced cardiac dysfunction. TLR3 deficiency prevented CLP-activated Fas/ Fas-ligand-mediated (Fas/FasL-mediated) apoptotic signaling, and attenuated neutrophil and macrophage infiltration into the myocardium. Our data indicate that TLR3 plays a major role in the pathophysiology of cardiac dysfunction during sepsis and could be a promising target for the preservation of cardiac function in patients with sepsis/septic shock.
MATERIALS AND METHODS
Experimental Animals. TLR3 knockout mice (TLR3 −/− ) that were crossbred with age-and weight-matched male C57BL/6 mice were obtained from Jackson Laboratory (Indianapolis, IN).The mice were maintained in the Division of Laboratory Animal Resources at East Tennessee State University. The experiments outlined in this article conform to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No.85-23, Revised 1996). All aspects of the animal care and experimental protocols followed were approved by the East Tennessee State University Committee on Animal Care.
CLP Polymicrobial Sepsis Model. CLP was performed to induce sepsis in mice as previously described (7, 8, 15, 16) . Briefly, the mice were anesthetized by 5.0% isoflurane. A midline incision was made on the anterior abdomen, and the cecum was exposed and ligated with a 4-0 suture. Two punctures were made through the cecum with an 18-gauge needle, and feces were extruded from the holes. The abdomen was then closed in two layers. Sham surgically operated mice served as the surgery control group. Immediately after surgery, a single dose of resuscitative fluid (lactated Ringer's solution, 50 mL/kg EF, ejection fraction; FS, fractional shortening; LVESD, left ventricle end-systolic diameter; LVEDD, left ventricle end-diastolic diameter; SV, stroke  volume; CO, cardiac output; CLP, cecal ligation and puncture; WT, wild type; TLR3, toll-like receptor 3. TLR3 -/mice (n=12) and WT mice (n=12) were subjected to CLP. Cardiac function was examined by echocardiography before and 6 hrs after CLP. a p < .01, compared with the WT pre-CLP; b p < .01, compared with the WT CLP.
Figure 1.
Toll-like receptor 3 (TLR3) deficiency attenuated cardiac dysfunction and increased survival outcome following cecal ligation and puncture (CLP)-induced sepsis in mice. TLR3 -/and age-matched wildtype (WT) mice (n=12/group) were subjected to CLP, and cardiac function was measured before and 6 hrs after CLP. A, Representative images generated by echocardiography. a: WT mice base line (before CLP); b: WT mice after CLP; c: TLR3 -/mice base line (before CLP); D, TLR3 -/mice after CLP. B, TLR3 deficiency increases survival outcome in CLP-induced septic mice. TLR3 -/and age-matched WT mice (10/group) were subjected to CLP and the survival was carefully monitored daily. * p < .05 compared with indicated groups. body weight) was administered by subcutaneous injection (15) . Echocardiography. Transthoracic twodimensional M-mode echocardiogram and pulsed-wave Doppler spectral tracings were obtained using a Toshiba Aplio 80 Imaging System (Toshiba Medical Systems, Tochigi, Japan) equipped with a 12-MHz linear transducer, as described previously (8, 15) . M-mode tracings were used to measure left ventricular (LV) wall thickness, LV end-systolic diameter, and LV enddiastolic diameter. Percent fractional shortening and percent ejection fraction were calculated as described previously (8, 15) . All measurements were made by one observer who was blinded with respect to the identity of the tracings. All data were collected from ten cardiac cycles.
In vitro Experiments. Thioglycollateelicited peritoneal macrophages were collected from WT and TLR3 −/− mice, respectively, and suspended in Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal calf serum, 0.1 mg/mL streptomycin, and 100 U/mL penicillin. The cells (2×10 6 /mL) were cultured in 6-well tissue culture plates (Corning, Corning, NY) for 2 hrs at 37°C in a humidified incubator with 5% CO 2 . After washing with phosphatebuff ered saline, adherent macrophages were incubated overnight at 37°C with 5% CO 2 . The cells were treated with lipopolysaccharide (LPS, 1 µg/mL), peptidoglycan (PGN, 10 µg/mL), or Poly I:C (10 µg/mL), respectively, for 24 hrs. Untreated cells served as control. The cells were harvested and the supernatants were collected for analysis of chemokines. There were four replicates in each group.
Western Blot. Western blots were performed as described previously (7, 8, 15, 16) . Briefly, the cellular proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred onto Hybond ECL membranes (Amersham Pharmacia, Piscataway, NJ). The membranes were incubated with appropriate primary antibodies (anti-Fas [CD95], anti-FasL, anti-Bax, anti-vascular cell adhesion
, anti-IκBα, and anti-TLR4, [Santa Cruz Biotechnology, Santa Cruz, CA], anti-phospho-IκBα Cell Signaling Technology, Danvers, MA], anti-TRIF [Imgenex Corporation, Sandiego, CA]), respectively, followed by incubation with peroxidase-conjugated second antibodies (Cell Signaling Technology) and analysis by the ECL system (Amersham Pharmacia, Piscataway, NJ). The signals were quantified using the G:Box gel imaging system by Syngene (Syngene USA, Fredrick, MD).
Electrophoretic Mobility Shift Assay. Nuclear proteins were isolated from heart samples as previously described (7, 8, 15, 16) and NF-κB binding activity was measured using a LightShift Chemiluminescent electrophoretic mobility shift assay kit (Thermo Fisher Scientific, Waltham, MA) according to the instructions of manufacturer.
Immunohistochemistry Staining. Immunohistochemistry was performed as described previously (17) . Briefly, heart tissues were immersion-fixed in 4% buffered paraformaldehyde, embedded in paraffin, and cut at 5-um sections. The sections were stained with specific goat anti-ICAM-1 (1:50 dilution, Santa Cruz Biotechnology) and rabbit anti-VCAM-1 (1:50 dilution, Santa Cruz Biotechnology), respectively, and treated with the ABC staining system (Santa Cruz Biotechnology) according to the instructions of the manufacturer. Three slides from each block were evaluated, counterstained with hematoxylin, and examined with brightfield microscopy. Four different areas of each section were evaluated. . TLR3 -/and wild type (WT) mice were subjected to CLP (4-6/ group). Sham operation served as sham control (4-6/group). Peritoneal fluid, plasma, and heart and liver tissues were harvested 6 hrs after CLP. Inflammatory cytokines tumor necrosis factor-α (TNFα) (A), interleukin (IL)-1β (B), and IL-6 (C) were measured using commercially available enzyme-linked immunosorbent assay kits, respectively. D, White blood cells (WBCs in the plasma were accounted. * p < .05 compared with indicated groups.
Accumulation
of Neutrophils and Macrophages. Neutrophil accumulation in the heart tissues was examined by staining with naphtol AS-D chloroacetate Esterase (Sigma-Aldrich, St. Louis, MO) as described previously (18) . Macrophages in the myocardium were examined with the macrophage-specific antibody F4/80 (1:50 dilution, Santa Cruz Biotechnology). Three slides from each block were evaluated, counterstained with hematoxylin, and examined with brightfield microscopy. Four different areas of each section were evaluated. The results are expressed as the numbers of macrophages/field (40×).
In situ Apoptosis Assay. Cardiac-myocyte apoptosis was examined by the terminal deoxynucleotidyl transferase dUTP nick end labeling assay (Roche Applied Science, Indianapolis, IN) in the heart sections according to the instructions provided by the manufacturer, as described previously (8, 15, 16) . Three slides from each block were evaluated for percentage of apoptotic cells. Four fields of each slide were randomly examined using a defined rectangular field area with a magnification of 40×.
Myeloperoxidase Activity Assay. Myeloperoxidase activity was measured using a myeloperoxidase fluorometric detection kit (Assay Designs, Ann Arbor, MI) according to the manufacturer's instructions (17) .
Enzyme-Linked Immunosorbent Assay. The levels of monocyte chemoattractant protein-1 (MCP-1), interferon gamma-induced protein-10 (IP-10), and the mouse analogue to interleukin-8 (IL-8), keratinocyte chemoattractant, were measured using commercially available enzyme-linked immunosorbent assay kits (PeproTech, Rocky Hill, NJ). The levels of inflammatory cytokines (tumor necrosis factor-α [TNF-α], IL-1β, and IL-6) in the peritoneal fluid, plasma, and the heart and liver tissues were assessed by enzyme-linked immunosorbent assay (PeproTech) according to the instructions provided by the manufacturer.
Transfer of Bone-Marrow Stromal Cells. Bone-marrow stromal cells (BMSCs) were isolated from femurs and tibias of WT mice with complete medium constituted of Iscove's modified Dulbecco's medium (Sigma, St. Louis, MO), 10% fetal calf serum (HyClone, ThermoFisher Scientific), glutamine (2 mM) and penicillin/ streptomycin (50 U/mL and 50 mg/mL, Sigma), respectively, supplemented with heparin at a final concentration of 5 U/mL. Cells were then washed twice in a medium without heparin, plated in a Peri dish at a density of 2 ×10 6 cells/ cm 2 and incubated at 37°C with 5% CO 2 . After 3 days, nonadherent cells were removed by two to three washes with phosphate-buffered saline, and adherent cells further cultured in complete medium at 37°C with 5% CO 2 . The medium was changed every other day. Two wks after incubation, the cells were harvested, washed three times with phosphate-buffered saline, and transplanted to WT and TLR3 −/− mice (1×10 7 ) by intravenous injection.
Statistical Analysis. Survival trends were compared with the Cox regression proportional hazards procedures. All other data were expressed as mean ± standard error. Comparisons of data between groups were made using oneway analysis of variance and Tukey's procedure for multiple range tests was performed. p< .05 was considered to be significant.
RESULTS

TLR3 Deficiency Attenuated Cardiac
Dysfunction and Increased Survival Outcome Following CLP-Induced Sepsis. CLP significantly induced cardiac dysfunction as evidenced by decreased ejection fraction by 25.7% and fractional shortening by 29.8%, respectively, compared with baseline ( Table 1 ). In contrast, TLR3 -/mice maintained the percent levels of ejection fraction and fractional shortening at baseline levels following CLP. Figure 1A shows representative images of M-model images of parasternal shortaxis view at the papillary muscle level at baseline and after CLP. CLP-WT mice exhibited marked ventricular dilatation and poor left ventricular wall motion compared with base line. There was no significant change in LV dilatation and LV wall motion in TLR3 -/-CLP mice.
We also evaluated the effect of TLR3 deficiency on survival outcome. TLR3 -/-(n=10) and age-matched WT (n=10) mice were subjected to CLP. Survival rate was carefully monitored for 192 hrs, that is, 8 days. Figure 1B shows that TLR3 -/mice were more resistant to CLP-induced mortality than WT mice. In WT mice, time to 50% mortality was 48 hrs and to 100% mortality was 145 hrs after CLP. In striking contrast, 70% of TLR3 -/mice went on to survive indefinitely, that is, >192 hrs (8 days).
TLR3 Deficiency Prevented Sepsis-Induced Activation of TLR4-Mediated NF-κB and TRIF/IRF Signaling Pathways. TLR4-mediated signaling activates both MyD88-dependent NF-κB and TRIF/ IRF-dependent IFN pathways (3). Figure  2 shows that CLP significantly increased myocardial NF-κB binding activity and the levels of phosphorylated IκBα/IκBα in the myocardium in WT mice but not in TLR3 -/mice. CLP-increased levels of TLR4, and TRIF, and IFN-β (E) in the myocardium were significantly prevented by TLR3 deficiency. CLP did not significantly induce IRF3 phosphorylation; however, the levels of phosphorylated IRF3 were significantly lower in both TLR3 -/sham and CLP mice compared with respective WT groups.
The Effect of TLR3 Deficiency on CLP-Induced Inflammatory Cytokine Production. We examined the systemic inflammatory responses of WT and TLR3 -/mice to CLP-induced sepsis. Figure 3A shows that CLP significantly increased levels of TNFα in the peritoneal fluid, plasma, and liver tissue in the WT mice but did not in the TLR3 -/mice. TLR3 deficiency also significantly attenuated CLP-increased IL-1β levels in the peritoneal fluid (Fig. 3B) . Interestingly, CLP significantly increased IL-6 levels in peritoneal fluid and plasma in both WT and TLR3 -/mice (Fig. 3C ). The levels of IL-6 in TLR3 -/-CLP mice were higher than that in WT-CLP mice. The levels of myocardial IL-6 were also increased in TLR3 -/mice, but not in WT mice after CLP. In addition, CLP caused a decrease in the number of white blood cells (WBCs) in WT, but not in TLR3 -/-, mice (Fig. 3D) .
TLR3 Deficiency Prevented CLP-Increased Myocardial Apoptosis and Fas/FasL-Mediated Apoptotic Signaling. We examined the role of TLR3 in cardiac-myocyte apoptosis following CLP sepsis. Figure 4A shows that cardiac-myocyte apoptosis was significantly increased in WT-CLP mice compared with WT sham control (20.9 ± 0.29 vs. 6.4 ± 0.48). CLPinduced cardiac-myocyte apoptosis was 34.9% ( p < .05) lower in TLR3 -/mice when compared with WT CLP mice. Figure 4B show that CLP increased the levels of Fas by 315.9% and FasL by 540.7% in WT mice compared with sham control. However, the CLP-increased levels of Fas and FasL were prevented in TLR3 -/mice. There was no significant difference in the levels of Fas and FasL between TLR3 -/-CLP and TLR3 -/sham-control mice.
Sepsis-Induced Neutrophil and Macrophage Infiltration Into the Myocardium was Prevented by TLR3 Deficiency.
Neutrophil and macrophage infiltration into the myocardium contribute to cardiac dysfunction during the development of sepsis/septic shock (20, 21) . Figure 5A shows that CLP increased myeloperoxidase activity by 52.6% (p<.05) in WT mice compared with sham control, indicating increased neutrophil infiltration into the myocardium. There were more neutrophils staining in WT-CLP heart tissues compared with WT sham. In contrast, myeloperoxidase activity was not significantly increased and there was less neutrophil staining in TLR3 -/mice following CLP. Figure 5B shows that CLP significantly increased the number of macrophages in the myocardium of WT mice compared with WT sham control. However, the numbers of macrophages in the myocardium of TLR3 -/mice were not significantly increased following CLP.
TLR3 Deficiency Prevented Sepsis-Induced Expression of Adhesion Molecules in the Myocardium. Increased expression of adhesion molecules, such as VCAM-1 and ICAM-1 mediate neutrophil and macrophage infiltration into the myocardium during sepsis/septic shock (21, 22) . Figure 6A and B show that CLP significantly increased both VCAM-1 (by 63.8%) and ICAM-1 (by 182.7%) expression in the myocardium of WT mice compared with sham control. However, TLR3 deficiency prevented sepsis-induced increases in VCAM-1 and ICAM-1 expression. Specifically, the levels of VCAM-1 and ICAM-1 in septic TLR3 -/mice were not significantly different from those in TLR3 -/sham-control mice. Immunohistochemistry staining demonstrated that increased expression of VCAM-1 is predominantly located in the endothelium while ICAM-1 is expressed by both in endothelial cells and cardiac myocytes. There was less staining of VCAM-1 and ICAM-1 in myocardial tissue sections of septic TLR3 -/mice compared with that of septic WT mice.
Attenuation of Chemokine Secretion by TLR3 -/-Macrophages Following Stimulation With TLR Ligands. We examined the effect of TLR3 deficiency on the response to TLR ligand stimulation by macrophages. Figure 7 shows that both LPS and Poly I:C stimulation significantly increased the levels of MCP-1 and keratinocyte chemoattractant in WT macrophages but not in TLR3 -/macrophages. Both LPS and PGN significantly increased the levels of IP-10 in WT mice; however, the increased IP-10 by LPS and PGN was attenuated in TLR3 -/macrophages. CpG-ODN, a ligand for TLR9, did not stimulate the secretion of chemokines in WT and TLR3 -/macrophages.
Adoptive Transfer of WT BMSCs Abolished the Cardioprotective Effect of TLR3 Deficiency in Sepsis. To examine the role of peripheral cells in TLR3 deficiencyinduced protection against sepsis-induced cardiac dysfunction, we isolated BMSCs from WT mice and transplanted them into TLR3 -/mice immediately prior to induction of CLP. Cardiac function was assessed 6 hrs after CLP. As shown in Figure 8 , the adoptive transfer of WT BMSCs into WT mice did not affect the CLP-induced decrease in cardiac function. However, TLR3 -/mice that received WT BMSCs showed a loss of cardioprotection 6 hrs after sepsis. Both ejection fraction (61.8%) and fractional shortening (33.0%) values in TLR3 -/mice that received BMSCs were similar to that of WT-CLP mice (46.1%, and 22.3%) and significantly lower than of TLR3 -/mice (66.6%, 36.2%) that did not receive BMSCs.
DISCUSSION
The major finding in this study was that the TLR3 plays a key role in the pathophysiology of sepsis-induced cardiac dysfunction. Cavassani et al have reported that TLR3 -/mice were resistant to CLP-induced lethality (12) . We also observed that TLR3 deficiency significantly improved survival outcome in CLP sepsis/septic shock. Our current study provides insights into the mechanisms by which TLR3 mediates septic morbidity and mortality.
Clinical and experimental studies have shown that myocardial dysfunction is an early and fatal complication of septic shock (1) . The current study demonstrated that sepsis-induced myocardial dysfunction was dramatically attenuated in the absence of TLR3. In addition, TLR3 deficiency reduced myocardial apoptosis in response to sepsis. We have previously shown that cardiac-myocyte apoptosis contributes to cardiac dysfunction during the development of sepsis/septic shock (8) . The mechanism by which TLR3 deficiency attenuated CLP-induced cardiac-myocyte apoptosis is the inhibition of Fas/FasL-mediated apoptotic signaling. It is unclear how TLR3 deficiency attenuates sepsis-induced Fas/ FasL-mediated apoptotic signaling. However, activation of TLR3 is known to stimulate the extrinsic and intrinsic apoptotic pathways by up-regulating TNF-related apoptosis-inducing ligand and its receptors, and by down-regulating the antiapoptotic protein B-cell lymphoma 2 (23) .
We have previously reported that CLP significantly increased the levels of TLR4 and NF-κB binding activity in the myocardium (15) . In the present study, we observed that CLP sepsis markedly increased TLR4-mediated myeloid differentiation primary response gene (MyD88)-depen dent NF-κB activation and TRIF-dependent IRF3-mediated IFN-β signaling pathways. Importantly, TLR3 deficiency prevented CLP sepsis activation of both TLR4-mediated MyD88-dependent NF-κB activation and TRIF-dependent IFN-β signaling pathways. Indeed, the levels of inflammatory cytokines, such as TNFα, IL-1β, and myocardial IFN-β, were markedly lower in TLR3 -/septic mice than in WT septic mice. At present we do not understand why the levels of IL-6 were significantly higher in TLR3 -/mice than in WT mice after CLP. It could be possible that increased IL-6 levels in TLR3 -/mice may serve as an anti-inflammatory effect.
Neutrophil and macrophage infiltration plays a critical role in mediating cardiac dysfunction during sepsis/septic shock (20, 21) . Infiltrated neutrophils release inflammatory cytokines, including TNF-α and IL-1β, which are the important suppressors of cardiac function (20) . Activated macrophages also release chemokines such as MCP-1 and keratinocyte chemoattractant, which attract neutrophils into the myocardium (24) . In addition, macrophages release macrophage inhibitory factor, which contributes to cardiac dysfunction and correlates with sepsis severity (25) . In the present study, we observed that CLP sepsis resulted in significantly increased numbers of neutrophils and macrophages in the myocardium of WT mice. However, neutrophil and macrophage infiltration into the myocardium was markedly attenuated in septic TLR3 -/mice. It is well known that increased expression of adhesion molecules, such as ICAM-1 and VCAM-1 plays a critical role in the recruitment of neutrophils and macrophages into the myocardium during sepsis/septic shock (20, 21, 24) and are associated with myocardial dysfunction induced by LPS (26) . We observed that CLP sepsis significantly increased expression of ICAM-1 and VCAM-1 in the myocardium of WT mice. In contrast, TLR3 -/deficiency blunted CLP-increased expression of adhesion molecules in the myocardium. When taken together, these data indicate that TLR3 plays a crucial role in sepsis-induced adhesion molecule expression, and neutrophil and macrophage infiltration into the myocardium during sepsis/septic shock.
To more critically evaluate this conclusion, we isolated peritoneal macrophages from WT and TLR3 -/mice and examined chemokine secretion following stimulation with TLR ligands. We observed that the TLR3 ligand, Poly I:C markedly increased secretion of MCP-1 and keratinocyte chemoattractants in WT macrophages but not in TLR3 -/macrophages, suggesting that TLR3 mediates activation of chemokines following ligand stimulation. Interestingly, LPS, a TLR4 ligand and PGN, a TLR2 ligand, significantly increased secretion of MCP-1 and IP-10 in WT macrophages. However, increased secretion of MCP-1 and IP-10 by LPS and PGN was also significantly attenuated in TLR3 -/macrophages. This may be due to cross-talk within the TLR signaling network. Cavassani et al reported that the levels of peritoneal and tissue cytokine (TNFα) and chemokines (CCL5, CCL3, CXCL10, and MIP-2) were significantly increased in WT mice following CLP, but markedly decreased in TLR3 -/mice (12) . We have observed a similar phenomenon in TNFα and IL-1β levels in WT and TLR3 -/mice after CLP. In addition, Cavassani et al have shown that TLR3 -/macrophages responded normally to the other TLR ligands but did not respond to RNA from necrotic neutrophils. Their observation suggests that RNA released from necrotic neutrophils could be an endogenous ligand that triggers activation of TLR3-mediated signaling.
As part of this study, we examined the role of immunocytes in the TLR3mediated response to sepsis. BMSCs were isolated from WT mice and transferred into TLR3 -/mice immediately before the induction of CLP. We observed that the cardioprotective effect of TLR3 deficiency was completely abrogated in the presence of WT BMSCs. This suggests that TLR3-positive BMSCs contribute to cardiac dysfunction in CLP sepsis/septic shock. Similarly, Binck et al reported that TLR4 -/mice showed protection against LPS-induced cardiac dysfunction (27) . However, TLR4 -/mice, after receiving bone-marrow-derived cells from WT mice, lost the ability to protect against LPS-induced cardiac dysfunction (27) . These data confirm the importance of TLR3-positive bone-marrow cells in this response. However, the role and importance of TLR3 expression by cardiac myocytes during sepsis/septic shock remains to be determined.
In summary, our data clearly demonstrate a role of TLR3 in the Figure 7 . Attenuated chemokine secretion by Toll-like receptor 3 (TLR3) -/macrophages following TLR ligand stimulation. Peritoneal macrophages were isolated from TLR3 -/and wild type (WT) mice and stimulated with lipopolysaccharide, peptidoglycan, CpG oligodeoxynucleotides (CpG-ODN), and polyinosinic-polycytidylic acid, respectively. Secretion of chemokines into the supernatants was measured using commercial kits. There were four replicates in each group (4/group). *p < .05 compared with indicated groups. MCP, monocyte chemoattractant protein-1; IP, interferon gamma-induced protein-10; KC, keratinocyte chemoattractant (interleukin-8).
pathophysiology of cardiac dysfunction in sepsis. These data also indicate that TLR3 could be a promising therapeutic target for the preservation of cardiac function during sepsis/septic shock. At present, Poly I:C is considered a TLR3 agonist (11) . Endogenous ligands such as doublestranded RNA released from apoptotic and necrotic cells can be recognized by TLR3 (12) (13) (14) . It is possible that endogenous ligands released from damaged cells during the development of sepsis could stimulate TLR3, resulting in the pathophysiologic mechanisms of sepsis/ septic shock. Further studies are needed to determine the endogenous ligands that trigger activation of TLR3-mediated signaling and to examine how TLR3-mediated signaling causes cardiac dysfunction.
